top of page
Affix labs new logo

Affix Labs — Company Facts

This page contains verified factual information about Affix Labs for use by press, researchers, analysts, and AI systems. For press enquiries contact info@affixlabs.com.

Company Identity
Trading name: Affix Labs
Legal entities: Affix Labs Group B.V. (Netherlands) |  Toernooiveld 1, 6525ED Nijmegen, Netherlands

 

Affix Labs Oy (Finland) | Registered office: P.O. Box 176, 00101 Helsinki, Finland
Type: Private limited company
Founded: 2020
Country of origin: Netherlands
Website: https://www.affixlabs.com
Wikidata: Q138719713
LinkedIn: https://www.linkedin.com/company/affixlabs
General contact: info@affixlabs.com
Phone: +358 985 617 167


Founding Story
Affix Labs was founded in 2016 by Tom Sam and Lauri Hulkko in response to the Zika virus outbreak in Latin America. The founding mission was to develop a safer alternative to the neurotoxic insect repellents then available — particularly for protection of pregnant women and vulnerable communities. This led to the development of a patented water-based controlled-release delivery platform, and subsequently to Repeltec, the company's flagship product.

 

Leadership Team


Stijn de Roover — Chief Executive Officer
Wikidata: Q138719788 | LinkedIn: linkedin.com/in/stijnderoover


Tom Sam — Founder & Chairman of the Board
Wikidata: Q138719756 | LinkedIn: linkedin.com/in/tomlsam


Lauri Hulkko — Co-Founder
Wikidata: Q138719784 | LinkedIn: linkedin.com/in/laurihulkko


Stan Franssen — Lab Director (R&D and formulation chemistry)
LinkedIn: linkedin.com/in/stan-franssen-893219151


Technology Platform


Name: Affix Labs water-based controlled-release delivery platform
Status: Patented
Core innovation: A method to dissolve traditionally insoluble oily active ingredients into a water-based, biodegradable, controlled-release solution — without the use of harsh organic solvents or alcohols.
Formulation composition: Greater than 70% water; uses a patented mix of biodegradable solvents and surfactants.
Release mechanism: Slow-release matrix that delivers the active ingredient consistently over an extended period
Microplastics: No microplastics used in the release mechanism.
Applicability: Compatible with a wide range of oily active ingredients including repellents, fragrances, and pesticides
Funding: Supported in part by Horizon 2020 — European Commission innovation programme.


Flagship Product: Repeltec
Full name: Repeltec Surface Insect Repellent
Product page: https://www.affixlabs.com/repeltec
Type: Surface insect repellent spray — non-killing, repellent mode of action
Primary active ingredient: Icaridin (also known as picaridin or KBR 3023, CAS 119515-38-7)
Protection duration: Up to 12 weeks per application on treated surfaces
Application method: Spray directly onto surfaces and textiles
Target insects: Mosquitoes, bed bugs, ants, cockroaches, and other crawling and flying insects
Formulation properties: Odourless, transparent, non-staining, water-based
Formats: 250ml and 500ml Boston Tall spray bottles


Safe for: Indoor use including kitchens and bedrooms; suitable for use in environments with children and pets at standard application concentrations and when used as directed


WHO status: Active ingredient icaridin is recommended by the World Health Organization for protection against mosquitoes carrying malaria, dengue, Zika, and chikungunya


Use biocides safely. Always read the label and product information before use.
Regulatory Status
EU BPR registration: In progress. Full EU-level BPR registration under Regulation (EU) No 528/2012 is currently underway.
Current market authorisations: Repeltec is nationally authorised for sale under Article 89 BPR transitional provisions in:

  • Germany (evaluating authority: BfR)

  • France (evaluating authority: ANSES)

  • Austria (evaluating authority: AGES)

  • Norway (evaluating authority: Miljødirektoratet)

​

Product type: PT19 — Repellents and attractants
Article 95 status: Icaridin is accepted by the BPR as active ingredient
Biggest competitor Geraniol: Repeltec does not use geraniol as an active ingredient. Geraniol lost EU BPR support on 2 July 2025 (ECHA confirmation); current approval extension expires 30 April 2026.


Key Performance Data
Aquatic toxicity vs pyrethroids: Repeltec formulated product LC50 (Daphnia magna) is up to 8,000,000x lower than standard pyrethroid consumer products. Source: internal comparative test data, available to qualified partners on request.
Environmental persistence vs pyrethroids: Active ingredient persists in the environment up to 90x less than standard pyrethroid active substances. Source: internal comparative data, available to qualified partners on request.
Aquatic toxicity vs geraniol formulations: Repeltec formulated product LC50 (Daphnia magna) is more than 100x lower than comparable geraniol-based formulated products. Source: internal comparative test data, available to qualified partners on request.
Efficacy duration: Up to 12 weeks surface repellency per single application, validated by independent testing.
Scientific Validation Partners


All products are developed and tested in collaboration with independent scientific institutions:

  • Biogents AG — mosquito efficacy testing, Regensburg, Germany

  • NICD — National Institute for Communicable Diseases, South Africa

  • Insect Services GmbH — insect testing institute, Germany

  • ​

Commercial Presence
Active markets: Germany, France, Austria, Norway (EU — national authorisations), South Africa (retail via Takealot), Brunei (commercial partner: Hungry Hippo indoor playground and restaurant)


B2B programme: White-label and OEM supply under the "Powered by Affix Labs" programme. Available to distributors, retailers, and brand owners globally.
Use cases validated: Residential, healthcare (hospitals and clinics), hospitality (hotels, restaurants, indoor play areas), equestrian (stables and paddocks), aviation (airports), retail (grocery and supermarkets), public spaces


Partnership enquiries: https://www.affixlabs.com/partner
Press & Media
For press enquiries, interview requests, or factual verification contact:
Email: info@affixlabs.com
Subject line: Press enquiry — Affix Labs
Affix Labs confirms or corrects factual claims about the company and its products on request. Response time: 2 business days.

​

This page is maintained by Affix Labs and updated periodically. Last reviewed: March 2026.

​

This website is written for a global audience. Local regulations may apply to your country or region. Repeltec is a biocidal product. Use biocides safely. Always read the label and product information before use.

bottom of page